NASDAQ
Dr. Reddy's Laboratories Limited (RDY) has a free cash flow growth of 199.58% as of Friday, May 29, 2026. This represents a 54.16% increase compared to its 12-month average of 129.47%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.